Large genetic study uncovers new Alzheimer’s drug targets

1. juni 2026

Rapporteret af AI

A major analysis of genetic data has linked 127 gene locations to Alzheimer’s disease, including 48 previously unidentified ones. Researchers also flagged several genes as promising drug targets and highlighted changes in immune and nerve cells.

The study examined genome information from nearly 110,000 people diagnosed with Alzheimer’s and 74,000 others who had a parent with the condition. It compared these against data from 2.6 million people without the disease. This effort identified 127 associated gene locations, 48 of which are new findings.

Relaterede artikler

Scientists call for multi-pronged strategies against Alzheimer's

A team of researchers led by Professor Yan-Jiang Wang has published a review arguing that Alzheimer's disease requires integrated treatments targeting multiple factors, not single causes. New drugs like lecanemab and donanemab offer modest benefits by slowing decline, but fall short of reversal. The paper, in Science China Life Sciences, emphasizes genetics, aging, and systemic health alongside amyloid-beta and tau proteins.

USC researchers identify compounds targeting Alzheimer’s brain inflammation

26. maj 2026 Rapporteret af AI

Scientists at the University of Southern California have found experimental compounds that may reduce harmful brain inflammation associated with Alzheimer’s disease. The work focuses on the enzyme cPLA2 and people who carry the high-risk APOE4 gene.

Mechanic with Alzheimer's mutation avoids disease through heat exposure

Doug Whitney, a US mechanic carrying a genetic mutation that typically triggers early-onset Alzheimer’s disease, has reached his late 70s without symptoms. Researchers link his protection to decades of intense heat exposure in ship engine rooms. The case bolsters evidence that heat therapy may safeguard the brain against the condition.

Nanoparticles reduced amyloid-β and improved cognition in an Alzheimer’s mouse model, researchers report

17. maj 2026 Rapporteret af AI Faktatjekket

Researchers from the Institute for Bioengineering of Catalonia and collaborating institutions report that engineered “supramolecular” nanoparticles restored aspects of blood-brain barrier function in Alzheimer’s-model mice, rapidly lowering brain amyloid-β and producing improvements on behavioral and memory tests.

onsdag d. 20. maj 2026, 20.53

Large genetic study uncovers new Alzheimer’s drug targets

Relaterede artikler

Scientists call for multi-pronged strategies against Alzheimer's

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Mechanic with Alzheimer's mutation avoids disease through heat exposure

Nanoparticles reduced amyloid-β and improved cognition in an Alzheimer’s mouse model, researchers report

Study finds alzheimer's risk factors hit women harder

Indiana university team targets idol enzyme to treat alzheimer's

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

Scientists restore memory in Alzheimer's mice by blocking PTP1B

New blood test spots Alzheimer's via protein shape changes

Dette websted bruger cookies